Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statement of Changes in Shareholders' Equity

v3.25.4
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative adjustment for tax-related equity investment accounting changes
Cumulative adjustment for adoption of credit loss accounting standard
Preferred Stock
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative adjustment for tax-related equity investment accounting changes
Retained Earnings
Cumulative adjustment for adoption of credit loss accounting standard
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 273,197 $ (1,227) $ 184 $ 28,397 $ 58,953 $ 207,003 $ (1,227) $ 184 $ (21,156)
Beginning balance (in shares) at Dec. 31, 2022         7,996.8        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 26,305         26,305      
Net change in debt securities 573               573
Net change in debit valuation adjustments (686)               (686)
Net change in derivatives 3,919               3,919
Employee benefit plan adjustments (439)               (439)
Net change in foreign currency translation adjustments 1               1
Dividends declared:                  
Common (7,374)         (7,374)      
Preferred (1,649)         (1,649)      
Common stock issued under employee plans, net, and other (in shares)         45.4        
Common stock issued under employee plans, net, and other 1,981       $ 1,988 (7)      
Common stock repurchased (4,576)       $ (4,576)        
Common stock repurchased (in shares)         (146.7)        
Ending balance at Dec. 31, 2023 290,209     28,397 $ 56,365 223,235     (17,788)
Ending balance (in shares) at Dec. 31, 2023         7,895.5        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 26,973         26,973      
Net change in debt securities 158               158
Net change in debit valuation adjustments (127)               (127)
Net change in derivatives 2,428               2,428
Employee benefit plan adjustments 131               131
Net change in foreign currency translation adjustments (87)               (87)
Dividends declared:                  
Common (7,822)         (7,822)      
Preferred (1,613)         (1,613)      
Redemption of preferred stock (5,254)     (5,238)   (16)      
Common stock issued under employee plans, net, and other (in shares)         46.9        
Common stock issued under employee plans, net, and other 2,071       $ 2,075 (4)      
Common stock repurchased (13,104)       $ (13,104)        
Common stock repurchased (in shares)         (331.5)        
Ending balance at Dec. 31, 2024 293,963     23,159 $ 45,336 240,753     (15,285)
Ending balance (in shares) at Dec. 31, 2024         7,610.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 30,509         30,509      
Net change in debt securities 1,156               1,156
Net change in debit valuation adjustments (329)               (329)
Net change in derivatives 3,590               3,590
Employee benefit plan adjustments 319               319
Net change in foreign currency translation adjustments 23               23
Dividends declared:                  
Common (8,083)         (8,083)      
Preferred (1,445)         (1,445)      
Issuance of preferred stock 5,493     5,493          
Redemption of preferred stock (2,669)     (2,660)   (9)      
Common stock issued under employee plans, net, and other (in shares)         53.5        
Common stock issued under employee plans, net, and other 2,149       $ 2,181 (32)      
Common stock repurchased (21,433)       $ (21,433)        
Common stock repurchased (in shares)         (451.9)        
Ending balance at Dec. 31, 2025 $ 303,243     $ 25,992 $ 26,084 $ 261,693     $ (10,526)
Ending balance (in shares) at Dec. 31, 2025         7,212.5